Market Overview - U.S. stocks traded lower, with the Nasdaq Composite falling more than 100 points on Thursday. The Dow decreased by 0.05% to 48,972.29, the NASDAQ declined by 0.57% to 23,448.86, and the S&P 500 fell by 0.14% to 6,911.57 [1] - Information technology stocks dipped by 1.4% on Thursday [2] - European shares were mostly lower, with the eurozone's STOXX 600 slipping 0.3% and various national indices showing slight declines [7] - Asian markets closed lower, with Japan's Nikkei 225 falling 1.63% and Hong Kong's Hang Seng Index declining 1.17% [9] Company Performance - Acuity Inc. reported fiscal first-quarter 2026 results with a 20.2% year-over-year net sales growth to $1.14 billion, aligning with analyst expectations. The adjusted EPS was $4.69, surpassing the consensus estimate of $4.59 [3] - Flyexclusive Inc. shares surged 126% to $7.44 after being named an authorized Starlink Aviation dealer [8] - Enliven Therapeutics Inc. shares increased by 59% to $24.55 following positive initial data from a clinical trial for chronic myeloid leukemia [8] - Nuvve Holding Corp. shares rose by 46% to $5.11 after regaining Nasdaq compliance [8] - Immuneering Corp. shares dropped 35% to $5.45 after announcing updated survival and safety data from a clinical trial [8] - Acrivon Therapeutics Inc. shares fell 29% to $2.10 after announcing clinical data and plans for EU expansion [8] - CorMedix Inc. shares decreased by 25% to $8.33 following preliminary revenue results [8] Commodities - Oil prices increased by 1.9% to $57.03, while gold prices decreased by 0.6% to $4,436.20. Silver fell by 4.7% to $73.925, and copper dropped by 2.5% to $5.7120 [6]

Financial Data and Key Metrics Changes - The company achieved total revenue of over RMB 100 million, up 10% year over year, driven by structural optimization across business lines [10][23] - Gross profit rose 15.6% year over year, with gross margin improving by 0.8 percentage points [23][28] - Operating income and net income increased by 30% and 30.2% year over year, respectively, indicating a shift from scale expansion to quality growth [23][29] Business Line Data and Key Metrics Changes - Engineering solutions for intelligent projects, which contribute over 90% of revenue, delivered 13.4% year-over-year revenue growth [11][26] - Operation and maintenance of intelligent projects segment saw revenues decrease to RMB 4.3 million from RMB 4.9 million year over year [26] - Sales of intelligent system equipment and materials decreased to RMB 10,000 from RMB 1.67 million year over year [26] Market Data and Key Metrics Changes - The company signed 144 new engineering solutions contracts, a 76% increase year over year, indicating strong market demand [11][15] - The average contract value increased year over year, reflecting broad market recognition of the company's capabilities [11] Company Strategy and Development Direction - The company aims to establish its brand as a global benchmark in intelligent engineering while strengthening core domestic operations [18] - There is a focus on tech-driven execution and enhancing service for domestic customers to maintain stable cash flows [20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's resilience and ability to navigate macroeconomic conditions while laying a foundation for long-term sustainable growth [9][20] - The global boom in intelligent buildings presents an opportunity for the company to evolve from a domestic leader to a global benchmark [20] Other Important Information - The company holds Class 1 licenses in various engineering sectors, providing a competitive barrier as it potentially expands into overseas markets [17] - As of March 31, 2025, the company had obtained a total of 23 patents and 28 software copyrights, showcasing its commitment to R&D [17] Q&A Session Summary - There were no questions during the Q&A session, indicating a lack of immediate inquiries from participants [33]